Cargando…

Development and validation of a prognostic nomogram for IgA nephropathy

IgA nephropathy (IgAN) shows strong heterogeneity between individuals. IgAN prognosis is associated with pathological lesions and clinical indicators. However, simple tools for evaluating the clinical prognosis remain inadequate. Our objective was to develop an intuitive estimation tool for predicti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jian, Duan, Shuwei, Chen, Pu, Cai, Guangyan, Wang, Yong, Tang, Li, Liu, Shuwen, Zhou, Jianhui, Wu, Di, Shen, Wanjun, Chen, Xiangmei, Wu, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706880/ https://www.ncbi.nlm.nih.gov/pubmed/29212234 http://dx.doi.org/10.18632/oncotarget.21721

Ejemplares similares

Profiling and initial validation of urinary microRNAs as biomarkers in IgA nephropathy
por: Wang, Nannan, et al.
Publicado: (2015)

Proteomic profiling of IgA nephropathy reveals distinct molecular prognostic subtypes
por: Chen, Xizhao, et al.
Publicado: (2023)

Potential Association of Body Constitution with the Prognosis of IgA Nephropathy: A Long-Time Follow-Up of 203 Cases in China
por: Liu, Linchang, et al.
Publicado: (2019)

Nomogram prediction model for renal anaemia in IgA nephropathy patients
por: Li, Fei, et al.
Publicado: (2021)

Development and assessment of a predictive nomogram for the progression of IgA nephropathy
por: Liu, Lin-lin, et al.
Publicado: (2018)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

Relationship between Traditional Chinese Medicine Syndrome Elements and Prognosis of Patients with IgA Nephropathy
por: Ke, Jianghua, et al.
Publicado: (2022)

Prognostic value of low-density lipoprotein cholesterol in IgA nephropathy and establishment of nomogram model
por: Tian, Zhang-Yu, et al.
Publicado: (2023)

Validation of the Oxford classification of IgA nephropathy for pediatric patients from China
por: Le, Weibo, et al.
Publicado: (2012)

A novel prognostic nomogram predicts premature failure of kidney allografts with IgA nephropathy recurrence
por: Bednarova, Kamila, et al.
Publicado: (2023)

A Validation Study Comparing Risk Prediction Models of IgA Nephropathy
por: Ouyang, Yan, et al.
Publicado: (2021)

The Emerging Role of Pathogenesis of IgA Nephropathy
por: Wu, Meng-Yu, et al.
Publicado: (2018)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

A novel clinical−radiomic nomogram for the crescent status in IgA nephropathy
por: Qin, Xiachuan, et al.
Publicado: (2023)

Nomogram for the prediction of crescent formation in IgA nephropathy patients: a retrospective study
por: Lin, Zaoqiang, et al.
Publicado: (2023)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

IgA nephropathy to proliferative glomerulonephritis with monoclonal IgAκ deposits: a pattern switch
por: Li, Jin-pu, et al.
Publicado: (2023)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Diagnostic Potential of Plasma IgA1 O-Glycans in Discriminating IgA Nephropathy From Other Glomerular Diseases and Healthy Participants
por: Zhang, Shuyu, et al.
Publicado: (2022)

IgA nephropathy with leucocytoclastic vasculitis
por: Wei, Lin-Yan, et al.
Publicado: (2018)

Increased Lifetime Risk of ESRD in Familial IgA Nephropathy
por: Shi, Manman, et al.
Publicado: (2020)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy
por: Chen, Pei, et al.
Publicado: (2018)

MicroRNAs in IgA nephropathy
por: Yao, Xingchen, et al.
Publicado: (2021)

Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis
por: Niu, Xia, et al.
Publicado: (2023)

Utilizing the MEST score for prognostic staging in IgA nephropathy
por: Haaskjold, Yngvar Lunde, et al.
Publicado: (2022)

Role of telitacicept in the treatment of IgA nephropathy
por: Wu, Lijun, et al.
Publicado: (2023)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Aberrant IgA1 Glycosylation in IgA Nephropathy: A Systematic Review
por: Sun, Qiang, et al.
Publicado: (2016)

A validation study of crescents in predicting ESRD in patients with IgA nephropathy
por: Zhang, Xiaoyan, et al.
Publicado: (2018)

Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome?
por: He, Jia-Wei, et al.
Publicado: (2022)

Landscape of intestinal microbiota in patients with IgA nephropathy, IgA vasculitis and Kawasaki disease
por: Hu, Xueli, et al.
Publicado: (2022)

Tripterygium Wilfordii inhibits tonsillar IgA production by downregulating IgA class switching in IgA nephropathy
por: Li, Huining, et al.
Publicado: (2017)

IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank
por: Sukcharoen, Kittiya, et al.
Publicado: (2020)

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports
por: Tota, Maciej, et al.
Publicado: (2023)

Identification and external validation of IgA nephropathy patients benefiting from immunosuppression therapy
por: Chen, Tingyu, et al.
Publicado: (2020)

IgA nephropathy with podocytic infolding glomerulopathy
por: Wang, Zhouyang, et al.
Publicado: (2023)

ELL2 Is Downregulated and Associated with Galactose-Deficient IgA1 in IgA Nephropathy
por: Liu, Youxia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rgrhfd1p73iiq6gujgrag50u70